Anderson brings to Biosion 18 years of diversified global finance experience in the Asia, US & European markets with a main focus on the healthcare industry, covering end-to-end from Discovery through commercialization. He leads Biosion’s Finance organization in driving compliance, strategic and budget planning and creating robust & effective systems and processes.

Prior to joining Biosion, Anderson was the global executive finance director of Wuxi Apptec where he headed the global FP&A, finance BP and finance system IT team with 50+ finance & IT professionals. He managed the financials of 20+ global BU across Asia, US & Europe as well as the public company statutory reporting of this 75Bn $ CRDMO giant. He was also the FP&A director of Gilead Science China where he contributed in the establishment of the China finance infrastructure from scratch by supporting the China general manager on financial planning of all commercial products launch from CDE registration to NRDL reimbursement. Mr. Zhang was the BU finance controller in J&J in both Pharmaceutical and Medical Device sectors in the U.S. and China. Anderson rotated globally in 4 different finance roles to learn how to manage the complexity of global financial matters in this multinational healthcare giant.  

Anderson holds a Bachelor Degree in Computer Science from Nanjing University and a MBA degree from the Stern Business School of New York University.  He is also a US Chartered Management Accountant, International Certified Public Accountant and an Associate Member of AIA.